Viridian Therapeutics, Inc. (VRDN)
24.18
+0.16
(+0.67%)
USD |
NASDAQ |
Aug 25, 16:00
24.18
0.00 (0.00%)
After-Hours: 19:59
Viridian Therapeutics Total Assets (Quarterly) : 1.097B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.097B |
| March 31, 2026 | 789.02M |
| December 31, 2025 | 899.42M |
| September 30, 2025 | 577.14M |
| June 30, 2025 | 582.32M |
| March 31, 2025 | 660.98M |
| December 31, 2024 | 742.40M |
| September 30, 2024 | 771.90M |
| June 30, 2024 | 585.66M |
| March 31, 2024 | 630.38M |
| December 31, 2023 | 490.42M |
| September 30, 2023 | 328.76M |
| June 30, 2023 | 351.47M |
| March 31, 2023 | 386.64M |
| December 31, 2022 | 435.09M |
| September 30, 2022 | 440.58M |
| June 30, 2022 | 169.81M |
| March 31, 2022 | 183.16M |
| December 31, 2021 | 203.71M |
| September 30, 2021 | 221.20M |
| June 30, 2021 | 118.20M |
| March 31, 2021 | 122.83M |
| December 31, 2020 | 131.26M |
| September 30, 2020 | 32.83M |
| June 30, 2020 | 33.48M |
| Date | Value |
|---|---|
| March 31, 2020 | 39.05M |
| December 31, 2019 | 30.26M |
| September 30, 2019 | 38.81M |
| June 30, 2019 | 48.78M |
| March 31, 2019 | 54.95M |
| December 31, 2018 | 66.15M |
| September 30, 2018 | 76.55M |
| June 30, 2018 | 81.89M |
| March 31, 2018 | 86.99M |
| December 31, 2017 | 52.48M |
| September 30, 2017 | 47.08M |
| June 30, 2017 | 50.03M |
| March 31, 2017 | 57.79M |
| December 31, 2016 | 24.76M |
| September 30, 2016 | 7.541M |
| June 30, 2016 | 9.042M |
| March 31, 2016 | 10.80M |
| December 31, 2015 | 12.90M |
| September 30, 2015 | 14.80M |
| June 30, 2015 | 13.09M |
| March 31, 2015 | 15.75M |
| December 31, 2014 | 8.089M |
| September 30, 2014 | 9.525M |
| June 30, 2014 | 10.66M |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 435.14M |
| Shareholders Equity (Quarterly) | 662.10M |
| Debt to Equity Ratio | 0.3668 |
| Current Ratio | 16.95 |
| Net Debt Paydown Yield | -2.11% |